Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jul 1;162(1):45-59.
doi: 10.1084/jem.162.1.45.

Early events in Epstein-Barr virus infection provide a model for B cell activation

Early events in Epstein-Barr virus infection provide a model for B cell activation

D A Thorley-Lawson et al. J Exp Med. .

Abstract

We have used Epstein-Barr virus (EBV) infection in vitro to delineate two distinct stages in B cell activation. Previous studies have shown that the BLAST-2 (EBVCS) (EBV cell surface) activation antigen is expressed on a small fraction of B cells within 24 h of stimulation with a variety of agents, including mitogens and EBV. In this study, we have been able to isolate the BLAST-2 (EBVCS)+ cells early after activation/infection with EBV. These cells are small B cells that are actively synthesizing RNA but not DNA, and are, therefore, clearly distinct from large proliferating lymphoblasts. In addition, they contain multiple copies of the EBV genome, express the viral nuclear antigen (EBNA) and, most importantly, proceed to undergo transformation when placed back in culture. By comparison, the BLAST-2 (EBVCS)- population does not undergo transformation, even though a fraction of these cells are activated for RNA synthesis and express EBNA. Thus, using the EBV system, we have been able to show directly that an activated B cell first expresses the BLAST-2 (EBVCS) antigen concomitant with an increase in RNA synthesis, and then subsequently proceeds to differentiate into a proliferating lymphoblast.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1967 Sep 1;157(3792):1064-5 - PubMed
    1. Proc Soc Exp Biol Med. 1969 Oct;132(1):247-52 - PubMed
    1. Int J Cancer. 1973 May;11(3):499-520 - PubMed
    1. Int J Cancer. 1975 Jan 15;15(1):59-66 - PubMed
    1. Int J Cancer. 1975 Mar 15;15(3):377-84 - PubMed

Publication types